{"id":23443,"date":"2023-10-20T11:41:04","date_gmt":"2023-10-20T18:41:04","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=23443"},"modified":"2024-01-31T08:30:13","modified_gmt":"2024-01-31T08:30:13","slug":"myasthenia-gravis-vs-lambert-eaton-syndrome","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/zh\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/","title":{"rendered":"\u91cd\u75c7\u808c\u65e0\u529b\u4e0e\u5170\u4f2f\u7279\u00b7\u4f0a\u987f\u7efc\u5408\u5f81"},"content":{"rendered":"\n<p><span style=\"font-weight: 400;\"><a href=\"https:\/\/ameripharmaspecialty.com\/myasthenia-gravis\/myasthenia-gravis\/\">Myasthenia gravis<\/a> (MG) and Lambert Eaton syndrome (also known as Lambert Eaton myasthenic syndrome) are autoimmune neuromuscular disorders that affect muscle functions. These two muscle disorders are quite rare and can make simple tasks more challenging for individuals suffering from them. Because both conditions affect muscles, they are often misdiagnosed due to similarities in symptoms.\u00a0<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-642b5d12b9e5a9959292f89ee4d243c2\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tSpeak to a Specialist\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAbout Copay Assistance\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">To provide a clear understanding to patients or their caregivers about these two neuromuscular disorders, we will briefly explain the key differences between myasthenia gravis (MG) vs. Lambert Eaton syndrome (LEMS).<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">The article will also discuss how both conditions differ in terms of cause, risk factors, affected body parts, onset and progression, diagnosis, and affected population.&nbsp;<\/span><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/#What_Is_Myasthenia_Gravis\" >What Is Myasthenia Gravis?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/#What_Is_Lambert_Eaton_Myasthenic_Syndrome\" >What Is Lambert Eaton Myasthenic Syndrome?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/#Myasthenia_Gravis_vs_Lambert_Eaton_Syndrome_Key_Differences\" >Myasthenia Gravis vs. Lambert Eaton Syndrome: Key Differences<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/#Causative_Factors\" >Causative Factors<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/#Onset_and_Progression\" >Onset and Progression<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/#Affected_Populations\" >Affected Populations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/#Diagnosis_of_Myasthenia_Gravis_vs_Lambert_Eaton_Syndrome\" >Diagnosis of Myasthenia Gravis vs. Lambert Eaton Syndrome<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/#Treatment_Procedures_for_MG_and_LEMS\" >Treatment Procedures for MG and LEMS<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/#Conclusion\" >Conclusion<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Myasthenia_Gravis\"><\/span>What Is Myasthenia Gravis?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Myasthenia gravis is a chronic and relatively rare autoimmune disorder that causes muscle weakness and severe fatigue. This condition occurs when communication between your nerves and muscles becomes disturbed at the neuromuscular junction (an area where the nerve and muscle connect).&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Normally, when a healthy person wants to move or lift something, the brain sends nerve impulses or signals. The nerve endings then release a substance called <a href=\"https:\/\/my.clevelandclinic.org\/health\/articles\/24568-acetylcholine-ach\">acetylcholine<\/a> that attaches to its receptor on the skeletal muscle cell and causes a muscle contraction.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">However, in people with MG, their immune system produces auto-antibodies that block or destroy the acetylcholine receptor sites at the neuromuscular junction and prevent muscle from contracting. Consequently, people with MG experience difficulty in performing tasks that require strong muscles, like lifting things and swallowing, etc.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Lambert_Eaton_Myasthenic_Syndrome\"><\/span>What Is Lambert Eaton Myasthenic Syndrome?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Lambert Eaton myasthenic syndrome is a rare autoimmune disorder that also occurs due to a communication breakdown between your nerves and muscle cells at the neuromuscular junction. This disruption leads to the gradual onset of muscle weakness.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">However, the mechanism of LEMS differs from MG. In this condition, auto-antibodies produced by the immune system block calcium channels on nerve endings. These channels are required for the release of acetylcholine from the nerve endings. When autoantibodies block these channels, less acetylcholine is released, which is insufficient to cause normal muscle contraction, and as a result, people with LEMS experience muscle weakness.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Myasthenia_Gravis_vs_Lambert_Eaton_Syndrome_Key_Differences\"><\/span>Myasthenia Gravis vs. Lambert Eaton Syndrome: Key Differences<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Even though both neuromuscular diseases occur as a result of communication breakdown between nerves and the muscles at the neuromuscular junction, they are distinct in the following ways:<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Causative_Factors\"><\/span>Causative Factors<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">The exact underlying cause of myasthenia gravis (MG) is still unknown. However, it is believed that a number of factors are involved in causing this condition, such as genetics, underlying disease (thymic tumor or thymoma), and immune factors.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">On the other hand, Lambert Eaton myasthenic syndrome (LEMS) is mainly <\/span><a href=\"https:\/\/www.mda.org\/disease\/lambert-eaton-myasthenic-syndrome\"><span style=\"font-weight: 400;\">associated with an underlying disease called small lung cancer in about 50% &#8211; 60% of cases<\/span><\/a><span style=\"font-weight: 400;\">. It is thought that when the immune system fights the cancer cells, it also inadvertently&nbsp;attacks the nerve endings because cancer cells contain some of the same proteins that are also present in nerve endings.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">However, normal individuals can also get LEMS, and in around 40% &#8211; 50% of cases, the cause is still unknown.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Onset_and_Progression\"><\/span>Onset and Progression<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">The onset of symptoms in individuals with MG can be sudden or gradual and the symptoms then progress over time. This condition first affects eye muscles and causes partial paralysis of eye movement. <\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9792103\/\"><span style=\"font-weight: 400;\">About half of the patients experience drooping eyelids (ptosis) or double vision (diplopia) as an initial symptom<\/span><\/a><span style=\"font-weight: 400;\">. Over time, muscle weakness spreads to other body parts, including facial, neck, and limb muscles, and could worsen if not treated in time.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">On the other hand, LEMS patients have subacute onset. Unlike MG, which affects the eye muscle first, LEMS causes proximal muscle weakness in the lower limbs (upper legs and hips), which leads to difficulty walking.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">With time, the muscle weakness temporarily improves after repetitive muscle activity, which is a unique feature of this condition.\u00a0<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-147cc77ae471d2c36e1c47ac6166aa7b\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tGet Financial Assistance for Your Medications\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Schedule a Consultation<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Affected_Populations\"><\/span>Affected Populations<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Myasthenia gravis and Lambert Eaton myasthenic syndrome can affect people of any age. However, MG is more prevalent in young women in their 20s or 30s and older men in their 60s or 70s. Conversely, LEMS is more common in middle-aged adults, especially those with small lung cancer and a history of smoking.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Diagnosis_of_Myasthenia_Gravis_vs_Lambert_Eaton_Syndrome\"><\/span>Diagnosis of Myasthenia Gravis vs. Lambert Eaton Syndrome<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/ct-scan.jpg\" alt=\"Patient undergoing CT scan to diagnose myasthenia gravis and lambert eaton syndrome\" class=\"wp-image-23446\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/ct-scan.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/ct-scan-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/ct-scan-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/ct-scan-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/ct-scan-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/ct-scan-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/ct-scan-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p><span style=\"font-weight: 400;\">Healthcare providers follow a series of tests for the diagnosis of MG, including clinical evaluation (medical history and physical test), blood test (to check anti-acetylcholine receptor antibodies [AChR] or anti-muscle-specific kinase antibodies related to MG), electromyography (to measure muscle and nerve function), and, in some cases, imaging studies like a chest CT to check associated conditions, such as thymus gland abnormalities.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Like MG, clinical evaluation, electromyography, and blood tests (to check voltage-gated calcium channel antibodies) are also used in the case of LEMS diagnosis. Sometimes, a CT scan is also recommended to check underlying associated disorders, such as small-cell lung cancer in patients.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Treatment_Procedures_for_MG_and_LEMS\"><\/span>Treatment Procedures for MG and LEMS<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Though there is no cure for MG and LEMS, several different treatment strategies and medications can help reduce disease-associated symptoms in patients.&nbsp;<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">In the case of MG, acetylcholinesterase inhibitors, corticosteroids, or immunosuppressive agents are prescribed.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">For LEMS, <a href=\"https:\/\/ameripharmaspecialty.com\/ivig\/ivig\/\/ivig\/\">immunoglobulin therapy<\/a>, <a href=\"https:\/\/ameripharmaspecialty.com\/?s=plasmapheresis\">plasmapheresis<\/a>, medication (such as amifampridine and pyridostigmine), and immunosuppressant agents are used.&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusion<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Myasthenia gravis and Lambert Eaton myasthenic syndrome are two autoimmune diseases that impact muscle functions and cause muscle weakness. While both diseases share similarities in symptoms, they differ in cause, risk factors, onset and progression, diagnosis and treatment, and the population they predominantly affect. Understanding the key differences between these two medical conditions can help patients and healthcare providers ensure accurate diagnosis and timely management.&nbsp;<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Myasthenia gravis (MG) and Lambert Eaton syndrome (also known as Lambert Eaton myasthenic syndrome) are autoimmune neuromuscular disorders that affect muscle functions. These two muscle disorders are quite rare and can make simple tasks more challenging for individuals suffering from them.<\/p>","protected":false},"author":25,"featured_media":23445,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[10],"tags":[31],"class_list":["post-23443","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-myasthenia-gravis","tag-dr-mark-alfonso"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Myasthenia Gravis vs. Lambert Eaton Syndrome - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn the key differences between myasthenia gravis vs. Lambert Eaton syndrome. We cover causative factors, diagnosis, treatment, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myasthenia Gravis vs. Lambert Eaton Syndrome - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Learn the key differences between myasthenia gravis vs. Lambert Eaton syndrome. We cover causative factors, diagnosis, treatment, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/zh\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-20T18:41:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-31T08:30:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Mark Alfonso, PharmD, BCMTMS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Mark Alfonso, PharmD, BCMTMS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/myasthenia-gravis\\\/myasthenia-gravis-vs-lambert-eaton-syndrome\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/myasthenia-gravis\\\/myasthenia-gravis-vs-lambert-eaton-syndrome\\\/\"},\"author\":{\"name\":\"Dr. Mark Alfonso, PharmD, BCMTMS\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/91fbbfa457730010998bc804c0467310\"},\"headline\":\"Myasthenia Gravis vs. Lambert Eaton Syndrome\",\"datePublished\":\"2023-10-20T18:41:04+00:00\",\"dateModified\":\"2024-01-31T08:30:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/myasthenia-gravis\\\/myasthenia-gravis-vs-lambert-eaton-syndrome\\\/\"},\"wordCount\":947,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/myasthenia-gravis\\\/myasthenia-gravis-vs-lambert-eaton-syndrome\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/autoantibodies.jpg\",\"keywords\":[\"Dr. Mark Alfonso\"],\"articleSection\":[\"Myasthenia Gravis\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/myasthenia-gravis\\\/myasthenia-gravis-vs-lambert-eaton-syndrome\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/myasthenia-gravis\\\/myasthenia-gravis-vs-lambert-eaton-syndrome\\\/\",\"name\":\"Myasthenia Gravis vs. Lambert Eaton Syndrome - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/myasthenia-gravis\\\/myasthenia-gravis-vs-lambert-eaton-syndrome\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/myasthenia-gravis\\\/myasthenia-gravis-vs-lambert-eaton-syndrome\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/autoantibodies.jpg\",\"datePublished\":\"2023-10-20T18:41:04+00:00\",\"dateModified\":\"2024-01-31T08:30:13+00:00\",\"description\":\"Learn the key differences between myasthenia gravis vs. Lambert Eaton syndrome. We cover causative factors, diagnosis, treatment, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/myasthenia-gravis\\\/myasthenia-gravis-vs-lambert-eaton-syndrome\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/myasthenia-gravis\\\/myasthenia-gravis-vs-lambert-eaton-syndrome\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/myasthenia-gravis\\\/myasthenia-gravis-vs-lambert-eaton-syndrome\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/autoantibodies.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/autoantibodies.jpg\",\"width\":1280,\"height\":853,\"caption\":\"3d illustration of autoantibodies blocking the acetylcholine transmitters in Myasthenia gravis (MG)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/myasthenia-gravis\\\/myasthenia-gravis-vs-lambert-eaton-syndrome\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myasthenia Gravis vs. Lambert Eaton Syndrome\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/91fbbfa457730010998bc804c0467310\",\"name\":\"Dr. Mark Alfonso, PharmD, BCMTMS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"caption\":\"Dr. Mark Alfonso, PharmD, BCMTMS\"},\"description\":\"Dr. Mark Alfonso, PharmD was born and raised in Pueblo, CO. He received his pharmacy degree from the University of Colorado School of Pharmacy at the Anschutz Medical Campus in 2010. He was board certified in medication therapy management in 2022. The most rewarding part of his job is helping to answer patient questions and concerns. His areas of expertise are community pharmacy and medication therapy management. In his free time, he enjoys reading and running.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/author\\\/mark-alfonso\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myasthenia Gravis vs. Lambert Eaton Syndrome - AmeriPharma\u00ae Specialty Care","description":"Learn the key differences between myasthenia gravis vs. Lambert Eaton syndrome. We cover causative factors, diagnosis, treatment, and more.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/zh\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/","og_locale":"zh_CN","og_type":"article","og_title":"Myasthenia Gravis vs. Lambert Eaton Syndrome - AmeriPharma\u00ae Specialty Care","og_description":"Learn the key differences between myasthenia gravis vs. Lambert Eaton syndrome. We cover causative factors, diagnosis, treatment, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/zh\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-10-20T18:41:04+00:00","article_modified_time":"2024-01-31T08:30:13+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg","type":"image\/jpeg"}],"author":"Dr. Mark Alfonso, PharmD, BCMTMS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Mark Alfonso, PharmD, BCMTMS","Est. reading time":"5 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/"},"author":{"name":"Dr. Mark Alfonso, PharmD, BCMTMS","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/91fbbfa457730010998bc804c0467310"},"headline":"Myasthenia Gravis vs. Lambert Eaton Syndrome","datePublished":"2023-10-20T18:41:04+00:00","dateModified":"2024-01-31T08:30:13+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/"},"wordCount":947,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg","keywords":["Dr. Mark Alfonso"],"articleSection":["Myasthenia Gravis"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/","url":"https:\/\/ameripharmaspecialty.com\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/","name":"Myasthenia Gravis vs. Lambert Eaton Syndrome - AmeriPharma\u00ae Specialty Care","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg","datePublished":"2023-10-20T18:41:04+00:00","dateModified":"2024-01-31T08:30:13+00:00","description":"Learn the key differences between myasthenia gravis vs. Lambert Eaton syndrome. We cover causative factors, diagnosis, treatment, and more.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/ameripharmaspecialty.com\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg","width":1280,"height":853,"caption":"3d illustration of autoantibodies blocking the acetylcholine transmitters in Myasthenia gravis (MG)"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/myasthenia-gravis\/myasthenia-gravis-vs-lambert-eaton-syndrome\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"Myasthenia Gravis vs. Lambert Eaton Syndrome"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"AmeriPharma\u00ae \u4e13\u4e1a\u62a4\u7406","description":"AmeriPharma \u7684\u4e13\u4e1a\u62a4\u7406","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"\u7f8e\u56fd\u5236\u836f\u4e13\u4e1a\u62a4\u7406","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/91fbbfa457730010998bc804c0467310","name":"Mark Alfonso \u535a\u58eb\uff0c\u836f\u5b66\u535a\u58eb\uff0cBCMTMS","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","caption":"Dr. Mark Alfonso, PharmD, BCMTMS"},"description":"Mark Alfonso \u535a\u58eb\uff0c\u836f\u5b66\u535a\u58eb\uff0c\u5728\u79d1\u7f57\u62c9\u591a\u5dde\u666e\u97e6\u5e03\u6d1b\u51fa\u751f\u957f\u5927\u3002\u4ed6\u4e8e 2010 \u5e74\u5728\u79d1\u7f57\u62c9\u591a\u5927\u5b66\u5b89\u8212\u8328\u533b\u5b66\u9662\u836f\u5b66\u9662\u83b7\u5f97\u836f\u5b66\u5b66\u4f4d\u3002\u4ed6\u4e8e 2022 \u5e74\u83b7\u5f97\u836f\u7269\u6cbb\u7597\u7ba1\u7406\u59d4\u5458\u4f1a\u8ba4\u8bc1\u3002\u4ed6\u5de5\u4f5c\u4e2d\u6700\u6709\u6210\u5c31\u611f\u7684\u90e8\u5206\u662f\u5e2e\u52a9\u89e3\u7b54\u60a3\u8005\u7684\u7591\u95ee\u548c\u62c5\u5fe7\u3002\u4ed6\u7684\u4e13\u4e1a\u9886\u57df\u662f\u793e\u533a\u836f\u623f\u548c\u836f\u7269\u6cbb\u7597\u7ba1\u7406\u3002\u95f2\u6687\u65f6\uff0c\u4ed6\u559c\u6b22\u9605\u8bfb\u548c\u8dd1\u6b65\u3002","url":"https:\/\/ameripharmaspecialty.com\/zh\/author\/mark-alfonso\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Mark Alfonso, PharmD, BCMTMS","author_link":"https:\/\/ameripharmaspecialty.com\/zh\/author\/mark-alfonso\/"},"uagb_comment_info":0,"uagb_excerpt":"Myasthenia gravis (MG) and Lambert Eaton syndrome (also known as Lambert Eaton myasthenic syndrome) are autoimmune neuromuscular disorders that affect muscle functions. These two muscle disorders are quite rare and can make simple tasks more challenging for individuals suffering from them.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/10\/autoantibodies.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Mark Alfonso, PharmD, BCMTMS","author_link":"https:\/\/ameripharmaspecialty.com\/zh\/author\/mark-alfonso\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/zh\/category\/myasthenia-gravis\/\" rel=\"category tag\">Myasthenia Gravis<\/a>","rttpg_excerpt":"Myasthenia gravis (MG) and Lambert Eaton syndrome (also known as Lambert Eaton myasthenic syndrome) are autoimmune neuromuscular disorders that affect muscle functions. These two muscle disorders are quite rare and can make simple tasks more challenging for individuals suffering from them.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts\/23443","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/comments?post=23443"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts\/23443\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/media\/23445"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/media?parent=23443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/categories?post=23443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/tags?post=23443"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}